Patents
Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958)
03/2003
03/27/2003DE20217570U1 Oxidative dyes for keratin fibers are based on a developer-coupler combination also containing (hetero)aromatic group-substituted 1,2-diaminobenzene derivatives, some of which are new compounds
03/27/2003CA2460440A1 Salicylic acid salts, processes for preparing them and their use as pharmaceutical compositions
03/26/2003EP1296142A2 Calcium receptor active molecules
03/26/2003EP1084099B1 Process for the preparation of protected 3-amino-1,2-dihydroxypropane acetal and derivatives thereof
03/26/2003CN1405145A 1,3,5-tri (4-amino phenoxy) benzene and preparation method thereof
03/26/2003CN1405144A 由海龙科动物提取的海龙素及其制法和用途 Dragon species extracted by Dragon hormone preparation and use
03/25/2003US6538152 Obesity, hyperglycemia, urinary incontinence, intestinal or biliary calculi hypermotility, pollakiuria and depression treatment
03/20/2003WO2003022259A1 Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites
03/20/2003US20030055038 For therapy of central nervous system and other disorders
03/20/2003US20030054200 Organic electroluminescence device
03/20/2003CA2460348A1 Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites
03/19/2003EP1292564A2 Aminoalcohol derivatives
03/19/2003EP1012131B1 Enantioselective reduction of ketones with a silane agent/metal compound/chiral ligand system
03/19/2003CN1404466A Stabilizing agent for hydroxylamine solutions
03/19/2003CN1403438A Novel aromatic diamine and its polyimide
03/18/2003US6534664 Polymerization catalysts
03/18/2003US6534200 Electroluminescent systems with polynulcear metal complexes
03/18/2003US6533936 Method for separation of optical isomers
03/18/2003CA2141334C Cationic lipids
03/13/2003WO2003020686A2 Method for producing 4-amino-1-naphthol ethers
03/13/2003WO2002102875A3 Polymers comprising cf2o structural elements
03/13/2003WO2002097050A3 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions
03/13/2003WO2002096901A3 1,3-dihydroxybenzene derivatives and colorants containing said compounds
03/13/2003WO2002074726A3 Aniline derivatives useful as phosphodiesterase 4 inhibitors
03/13/2003US20030050508 Reacting N-methyl-3-hydroxy-3-phenyl-propylamine with 1-chloro-4-(trifluoromethyl)benzene in the presence of alkaline metal hydroxide in sulfolane in the presence of a catalyst such as a crown ether or polyethylene glycol 6000
03/13/2003US20030050324 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents
03/13/2003US20030050317 (R)-chiral halogenated substituted n,n-bis-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
03/13/2003US20030049310 Genetic enginnering; inducing antibodies
03/12/2003EP1289926A2 A novel process for preparing salmeterol
03/12/2003EP1289514A1 Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
03/12/2003EP0942899B1 Manufacturing process of metoprolol
03/12/2003EP0672031B1 Catechol diethers as selective pde iv inhibitors
03/11/2003US6531632 Bis-o-aminophenols and o-aminophenolcarboxylic acids and process for preparing the same
03/11/2003US6531511 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
03/06/2003WO2003018762A2 Compositions that bind antiterminator rna and their assays
03/06/2003WO2003018534A1 A nitrogen-containing ortho ester-based surfactant, its preparation and use
03/06/2003WO2003018070A1 Stilbene derivatives and their use for binding and imaging amyloid plaques
03/06/2003WO2003017955A1 Oxidation hair dyes containing 3-aminophenol derivatives, and novel 3-aminophenol derivatives
03/06/2003WO2002085877A3 Processes and intermediates for preparing benzyl substituted epoxides
03/06/2003WO2002066415A8 Non-steroidal modulators of estrogen receptors
03/06/2003US20030045755 Polyamine analogues as cytotoxic agents
03/06/2003US20030045586 Use of amines
03/06/2003US20030044845 Novel therapeutic agents for membrane transporters
03/06/2003US20030044640 N,N'-di- to tetra- aryl substituted stilbenediamines; excellent heat resistance, a high efficiently of light emission and a long life and emits blue light of a high purity.
03/06/2003US20030041392 Process for making 1,4-diamino-2-methoxymethylbenzene and salts thereof and compositions and methods for dyeing keratin fibers containing same
03/06/2003CA2458507A1 Compositions that bind antiterminator rna and their assays
03/05/2003EP1288191A2 Novel aromatic diamine and polyimide thereof
03/05/2003EP1287006A1 Antitumoral compounds
03/05/2003EP1286978A1 Cyclohexyl derivatives and their use as therapeutic agents
03/05/2003EP1286952A2 Ester quaternary mixtures
03/05/2003EP1286951A1 Process for the separation of the cis trans diastereoisomers of tramadol
03/05/2003EP1286950A1 Method for producing arylpoly(oxalkyl)-benzyldimethyl-ammonium derivatives
03/05/2003EP1102737B1 Method for the conversion of 3- and 4-methylcatechol to benzaldehyde
03/05/2003EP1012134B1 Quaternary ammonium phosphate compounds and method of preparing the same
03/04/2003US6528685 Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
03/04/2003US6528455 Phenoxy-and thiophenoxy acrylic acid compounds as herbicides
02/2003
02/27/2003WO2003016261A1 Substituted octahydrophenanthrene compounds and their use as nmda antagonists
02/27/2003WO2002072542A3 Ph-dependent nmda receptor antagonists
02/27/2003US20030040545 (R)-Chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesteryl ester transfer protein activity
02/27/2003US20030040485 For use in theray
02/26/2003EP1284730A1 Aralkyl ester soft drugs
02/26/2003CN1399687A Method for producing optically active amines
02/26/2003CN1399626A Ethers of o-desmethyl venlafaxine
02/26/2003CN1399622A Triphenylalkene derivatives and their use as selective estrogen receptor modulators
02/25/2003US6525222 Process for preparing amines
02/25/2003US6525220 Intermediates for the synthesis of benzimidazole derivatives and a process for the preparation thereof
02/25/2003US6525210 Binaphthyl phospholanes, chelating phosphines and ferrocene complexes thereof
02/25/2003US6525199 Ring coupling, reduction and deprotecting; synthesis of compounds for alleviation and treatment of symptoms due to ischemic diseases
02/25/2003US6525068 Hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand
02/20/2003WO2003014061A1 Method for the production of amines by reductive amination of carbonyl compounds under transfer-hydrogenation conditions
02/20/2003WO2003014060A1 Process for the preparation of tolterodine
02/20/2003US20030036665 For use in the treatment of hair, fibers and textiles as softening and conditioning agents
02/20/2003US20030036569 Do not readily protonate (even in aqueous solutions of low pH), commonly encountered in many extreme applications due to the very low basicity of the perfluorinated anion.
02/20/2003US20030035835 Protective overcoatings
02/20/2003CA2456293A1 Process for the preparation of tolterodine
02/19/2003CN1398247A Colchinol derivatives as vascular damaging agents
02/19/2003CN1397544A Process for preparing 4,4-diaminodiphenyl ether
02/18/2003US6521793 Aromatic secondary amines; polymerization catalysts
02/18/2003US6521792 Through formation of hydrate via adding water or solvent; stoichiometry
02/18/2003US6521667 Calcilytic compounds
02/18/2003US6521607 (R)-chiral halogenated substituted N-phenoxy N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
02/13/2003WO2003012253A2 Method of controlling asphaltene precipitation in a fluid
02/13/2003WO2003011252A1 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety
02/13/2003WO2002076995A3 2-amino-propanol derivatives
02/13/2003US20030032644 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
02/13/2003CA2451868A1 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety
02/12/2003EP1283039A1 -secretase inhibitors
02/12/2003EP1282592A2 Use of amines
02/12/2003EP1150942A4 Improved compounds for protein binding
02/12/2003EP0861239B1 Biphenyl ether oxazolines and their use as pest-control agents
02/12/2003CN1396907A 3-phenoxy-1-phenyl acetylene derivatives and their use as herbicides
02/12/2003CN1396819A Novel coupler for use in oxidative hair dyeing
02/11/2003US6518450 Guaiacoxypropanolamines with alpha/beta adrenergic blocking activity
02/11/2003US6518316 Cytokine production and tyrosine kinase inhibitors
02/11/2003US6518314 Pharmaceutical agents that impede the initiation and progression of primary and secondary DMS disruptions
02/10/2003WO2002014336A1 Ruthenium complexes containing carboids
02/10/2003CA2419368A1 Ruthenium complexes containing carboids
02/06/2003WO2003010128A2 Perfluoroalkyl-substituted amines, acids, amino acids and thioether acids
02/06/2003WO2003010127A1 Novel aromatic compounds and organic electroluminescent devices made by using the same
02/06/2003US20030027859 3-aryl-2-hydroxypropionic acid derivative I
1 ... 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 ... 140